A phase I trial of emavusertib (CA-4948) in combination with gemcitabine and nab-paclitaxel in metastatic or unresectable pancreatic ductal adenocarcinoma (PDAC).

albumin-bound paclitaxel - Generic mfg.

gemcitabine - Generic mfg.

emavusertib (CA-4948) - Curis

https://www.asco.org/abstracts-presentations/265063/

Patrick Grierson; Farshid Dayyani; Susanna Ulahannan; Monica Patel; Mina Abdiannia; Amberly Brown; Kian-Huat Lim; Gulam Manji; Robert Lentz

Apr 21, 2026